Male Breast Cancer Completed Phase Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs